Banco Santander’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Banco Santander's IBB Position: Q2 2023 in Review
Banco Santander sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 2,730 shares — an estimated $353K sold.
Banco Santander first reported a position in IBB in Q4 2016 and held it in 2 quarters. The position peaked at $3.58M in Q4 2016. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.
- Banco Santander reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
- Banco Santander sold 2,730 iShares Biotechnology ETF shares in Q2 2023, an estimated $353K.
- Banco Santander first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 2 quarters.
- Banco Santander's iShares Biotechnology ETF position peaked at $3.58M in Q4 2016.
- 843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.
Based on Banco Santander's 13F filing for Q2 2023, filed 14 Aug 2023.